Generic drug industry blue ribbon panel
Lead-off speakers at June 20 hearing are Center for Drug Evaluation and Research Director Carl Peck, MD, and Office of Generic Drugs Acting Director Bruce Burlington, MD, followed by speakers representing the generic industry, testing labs, health insurers and medical professional societies. Established by the Generic Pharmaceutical Industry Association and chaired by former PMA President Lewis Engman, the panel convenes at 9:00 a.m. at the Georgetown University Hotel and Conference Center in Washington, D.C.
You may also be interested in...
Device companies operating in Canada are being advised to review their internal procedures in anticipation of new postmarket requirements that come into force this year.
Valneva is scaling up manufacture of its coronavirus vaccine alongside the clinical development program, with a view to meeting its commitment to provide millions of doses for use in the UK and the EU.
The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.